Navigation Links
MEI Development Corporation and GE Healthcare Sign Strategic Agreement
Date:5/18/2009

GE's Sole-Source Agreement Spans MEI's Broad Solution Offerings

CORAL SPRINGS, Fla., May 18 /PRNewswire/ -- MEI Development Corporation (MEI), a subsidiary of The MEI Healthcare Group, announced today a strategic agreement with GE Healthcare (NYSE: GE), a leading provider of healthcare technology. The sole-source, strategic agreement offers GE Healthcare's customers the option of MEI's broad solutions, including development, financial, oncology, women's health and consulting services.

"Our partnership with MEI provides a single, seamless platform for a comprehensive imaging solution," said Bob White, Senior Vice President, GE Healthcare. "When customers are provided with a robust, scalable model under one platform, the quality and cost of healthcare delivery improves."

"Our agreement ensures that MEI will continue to provide physician and hospital clients with seamless access to GE's industry-leading technology, which is fundamental to delivering MEI's comprehensive solution portfolio," said Gordon Baltzer, President and CEO of The MEI Healthcare Group.

MEI Development Corporation provides turnkey solutions for physicians, outpatient facilities and hospitals that are interested in adding and updating imaging technology. MEI offers a unique array of services including determining project viability, creation and implementation of business planning, procurement of imaging equipment and complete project financing.

About MEI: The MEI Healthcare Group, LLC, headquartered in Coral Springs, Florida, is a healthcare strategy firm that works with physician groups and medical centers to provide turnkey healthcare solutions for imaging and radiation therapy services.

About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com

    CONTACT:
    Nick Wasmiller
    Seyferth & Associates Inc.
    1-800-435-9539
    wasmiller@seyferthpr.com


'/>"/>
SOURCE MEI Development Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
2. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
3. arc Thrift Stores to Honor Individuals and Businesses Who Support People With Developmental Disabilities
4. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
5. iJET Provides Additional Services in Response to Ongoing H1N1 Influenza A (Swine Flu) Developments
6. Recent developments at Burnham Institute for Medical Research, May 2009
7. VIDEO from Medialink and the Society of Interventional Radiology: Prostate and Kidney Cancer - New Life-Changing Developments
8. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
9. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
10. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
11. Prematics Names S. Michael Ross Chief Medical Officer and Senior Vice President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... Boulder, CO (PRWEB) , ... January 13, 2017 , ... ... Congress, a growing alliance of deans of colleges and schools of education across the ... public schools. , In a Declaration of Principles released today, 175 deans sounded the ...
(Date:1/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a new ... way to peace, health and eternal joy. Yisrayl says he has been accused of being ... that false accusations and persecution are nothing new in his world and says it has ...
(Date:1/13/2017)... , ... January 13, 2017 , ... One way to ... nationals can qualify if they can show their work is in the national interest. ... self-petition rather than having to be sponsored by an employer; and 2) the submission ...
(Date:1/13/2017)... ... 13, 2017 , ... U.S. News & World Report highly ... its 2017 Best Online Graduate Nursing Programs list released Jan. 10. The School ... graduate degree programs include a family nurse practitioner doctor of nursing practice (DNP), ...
(Date:1/13/2017)... ... 2017 , ... PrideStaff, a national, franchised staffing organization ... franchise by Entrepreneur. , The 38th annual Franchise 500® ranking was determined using ... success. All entrants were judged by financial strength and stability, growth rate and ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Idaho , Jan. 12, 2017  Albertsons ... by Accreditation Commission for Health Care (ACHC) for ... largest national food and drug chain with this ... for pharmacy patients. Accreditation by ACHC ... national standards to facilitate a higher level of ...
(Date:1/13/2017)... 13, 2017  Biologics Prescribers Collaborative (BPC) ... (FDA) for issuing final guidance calling for ... policy is an important win for patients ... for pharmacovigilance, patient safety and transparency. ... to FDA, we remain concerned with "random" suffixes called ...
(Date:1/12/2017)... -- The global peripheral intravenous catheter market ... 3.8 Bn by 2016 end. Wide adoption of catheterization techniques in ... for PIVC. Rising disease prevalence will play a key role in ... likely to remain the largest market; Asia Pacific ... ...
Breaking Medicine Technology: